eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
12.20
-0.31 (-2.48%)
May 9, 2025, 4:00 PM - Market closed
Company Description
eXoZymes, Inc. a development stage company focused on building a technology platform that can develop assets that can be reapplied multiple times in different markets with only small changes, while maintaining and capturing new fundamental IP in the application.
The company produces chemicals, including pharmaceuticals, fuels, materials, food additives, colors, fragrance and novel compounds.
Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion.
The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025.
The company was founded in 2014 and is headquartered in Monrovia, California.
eXoZymes, Inc.
Country | United States |
Founded | 2014 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 31 |
CEO | Michael Heltzen |
Contact Details
Address: 750 Royal Oaks Drive, Suite 106 Monrovia, California 91016 United States | |
Phone | 626 415 1488 |
Website | exozymes.com |
Stock Details
Ticker Symbol | EXOZ |
Exchange | NASDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0002010788 |
ISIN Number | US4618741098 |
Key Executives
Name | Position |
---|---|
Michael Heltzen | President and Chief Executive Officer |
Dr. Tyler Korman Ph.D. | Co-Founder and Vice President of Research |
Dr. Paul Opgenorth Ph.D. | Co-Founder and Vice President of Development |
Fouad Nawaz | Vice President of Finance |
James U. Bowie Ph.D. | Founder and Independent Director |
Lasse H. Gorlitz | Vice President of Communications |
Michael Burns | Executive Vice President of Energy Transition |
Dr. Zachary Karl Ph.D. | Vice President and Head of Business Development |
Damien A. Perriman | Chief Commercial Officer |